Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v3-FR
Language English French
Date Updated 2021-11-25 2021-11-16
Drug Identification Number 02366460 02366460
Brand name REMIFENTANIL HYDROCHLORIDE FOR INJECTION REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Common or Proper name REMIFENTANIL HYDROCHLORIDE FOR INJECTION REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Company Name STERIMAX INC STERIMAX INC
Ingredients REMIFENTANIL REMIFENTANIL
Strength(s) 1MG 1MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS 10 VIALS
ATC code N01AH N01AH
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2021-11-16 2021-11-16
Estimated end date 2021-11-26 2021-11-26
Actual end date 2021-11-24
Shortage status Resolved Anticipated shortage
Company comments SteriMax regrets to inform that there has been an administrative release delay for Remifentanil 1 mg and we are currently encountering a supply interruption. We anticipate this being resolved by Friday November 26th. SteriMax regrets to inform that there has been an administrative release delay for Remifentanil 1 mg and we are currently encountering a supply interruption. We anticipate this being resolved by Friday November 26th.
Health Canada comments